Description

3-Piperidinecarboxamide,1-(4,6-Dimethyl-2-Pyrimidinyl)-n-6-Quinoxalinyl-(9Ci) is a high-purity, advanced pharmaceutical intermediate designed for research and development in modern drug discovery. This compound is valued for its complex heterocyclic structure, which serves as a critical building block in the synthesis of novel bioactive molecules. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers targeting therapeutic areas such as oncology and central nervous system (CNS) disorders.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel small-molecule drug candidates, particularly for targeted therapies.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization programs due to its unique piperidine-quinoxaline-pyrimidine scaffold.
• Kinase Inhibitor Development: Serves as a core structural motif in the research and development of potential kinase inhibitors for oncology applications.
• CNS Drug Discovery: Employed in the design and synthesis of compounds targeting neurological pathways and receptors.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for clinical trial materials.
• Academic Research: Used in university and institutional labs for fundamental chemical and pharmacological studies involving complex heterocycles.

Basic Information

Product Name	3-Piperidinecarboxamide,1-(4,6-Dimethyl-2-Pyrimidinyl)-n-6-Quinoxalinyl-(9Ci)
CAS No.	606106-24-5
Molecular Formula	C20H21N7O
Molecular Weight	375.43 g/mol
Synonyms	1-(4,6-Dimethylpyrimidin-2-yl)-N-(quinoxalin-6-yl)piperidine-3-carboxamide; 1-(4,6-Dimethyl-2-pyrimidinyl)-N-6-quinoxalinyl-3-piperidinecarboxamide; 3-Piperidinecarboxamide, 1-(4,6-dimethyl-2-pyrimidinyl)-N-6-quinoxalinyl-; UNII-8W2G3S4Q4F; 8W2G3S4Q4F; CHEMBL3186660; BDBM50157853; AKOS009158950
EINECS	Contact for details

Quality Control

Our 3-Piperidinecarboxamide,1-(4,6-Dimethyl-2-Pyrimidinyl)-n-6-Quinoxalinyl-(9Ci) is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing all specifications are provided and can be tailored to meet specific client requirements for research or cGMP-grade material.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). This material is light-sensitive (store away from light) and hygroscopic (moisture-sensitive). For long-term storage, consider using desiccants and an inert atmosphere to maintain stability.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.